These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 29486782)

  • 61. Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?
    Matney J; Park PC; Bluett J; Chen YP; Liu W; Court LE; Liao Z; Li H; Mohan R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):576-82. PubMed ID: 24074932
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intensity modulated proton arc therapy via geometry-based energy selection for ependymoma.
    Cao W; Li Y; Zhang X; Poenisch F; Yepes P; Sahoo N; Grosshans D; McGovern S; Gunn GB; Frank SJ; Zhu XR
    J Appl Clin Med Phys; 2023 Jul; 24(7):e13954. PubMed ID: 36913484
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
    Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
    Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.
    Kardar L; Li Y; Li X; Li H; Cao W; Chang JY; Liao L; Zhu RX; Sahoo N; Gillin M; Liao Z; Komaki R; Cox JD; Lim G; Zhang X
    Pract Radiat Oncol; 2014; 4(6):e259-68. PubMed ID: 25407877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beam angle comparison for distal esophageal carcinoma patients treated with intensity-modulated proton therapy.
    Feng H; Sio TT; Rule WG; Bhangoo RS; Lara P; Patrick CL; Korte S; Fatyga M; Wong WW; Schild SE; Ashman JB; Liu W
    J Appl Clin Med Phys; 2020 Nov; 21(11):141-152. PubMed ID: 33058523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multiple-CT optimization of intensity-modulated proton therapy - Is it possible to eliminate adaptive planning?
    Wang X; Li H; Zhu XR; Hou Q; Liao L; Jiang B; Li Y; Wang P; Lang J; Zhang X
    Radiother Oncol; 2018 Jul; 128(1):167-173. PubMed ID: 29054378
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dosimetric impact of random spot positioning errors in intensity modulated proton therapy plans of small and large volume tumors.
    Arjunan M; Krishnan G; Sharma DS; M P N; Patro KC; Thiyagarajan R; Srinivas C; Jalali R
    Br J Radiol; 2021 Mar; 94(1119):20201031. PubMed ID: 33529057
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 4D strategies for lung tumors treated with hypofractionated scanning proton beam therapy: Dosimetric impact and robustness to interplay effects.
    Mastella E; Molinelli S; Pella A; Vai A; Maestri D; Vitolo V; Baroni G; Valvo F; Ciocca M
    Radiother Oncol; 2020 May; 146():213-220. PubMed ID: 32222489
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning.
    Zeng C; Plastaras JP; Tochner ZA; White BM; Hill-Kayser CE; Hahn SM; Both S
    Phys Med Biol; 2015 Apr; 60(7):3013-29. PubMed ID: 25789418
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques.
    Verbakel WF; van Reij E; Ladenius-Lischer I; Cuijpers JP; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e297-303. PubMed ID: 22579380
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of proton therapy techniques for treatment of the whole brain as a component of craniospinal radiation.
    Dinh J; Stoker J; Georges RH; Sahoo N; Zhu XR; Rath S; Mahajan A; Grosshans DR
    Radiat Oncol; 2013 Dec; 8():289. PubMed ID: 24344645
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
    Liao Z; Lee JJ; Komaki R; Gomez DR; O'Reilly MS; Fossella FV; Blumenschein GR; Heymach JV; Vaporciyan AA; Swisher SG; Allen PK; Choi NC; DeLaney TF; Hahn SM; Cox JD; Lu CS; Mohan R
    J Clin Oncol; 2018 Jun; 36(18):1813-1822. PubMed ID: 29293386
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
    Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
    Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors.
    Simeonova A; Abo-Madyan Y; El-Haddad M; Welzel G; Polednik M; Boggula R; Wenz F; Lohr F
    Radiother Oncol; 2012 Feb; 102(2):268-73. PubMed ID: 22100654
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Novel Ultrahigh-Dose-Rate Proton Therapy Technology: Spot-Scanning Proton Arc Therapy + FLASH (SPLASH).
    Liu G; Zhao L; Li X; Zhang S; Dai S; Lu X; Ding X
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):730-737. PubMed ID: 37196836
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.
    Liu W; Liao Z; Schild SE; Liu Z; Li H; Li Y; Park PC; Li X; Stoker J; Shen J; Keole S; Anand A; Fatyga M; Dong L; Sahoo N; Vora S; Wong W; Zhu XR; Bues M; Mohan R
    Pract Radiat Oncol; 2015; 5(2):e77-86. PubMed ID: 25413400
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
    Giantsoudi D; Adams J; MacDonald S; Paganetti H
    Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.